Hematology and Oncology Book

DIC

  • Disseminated Intravascular Coagulation

http://www.fpnotebook.com/

Disseminated Intravascular Coagulation

Aka: Disseminated Intravascular Coagulation, Disseminated Intravascular Coagulopathy, DIC
  1. Causes
    1. Infection
      1. Gram NegativeSepsis
      2. Meningococcemia
      3. Rocky Mountain Spotted Fever
    2. Neoplastic disease
      1. Mucin-Secreting adenocarcinoma
      2. Promyelocytic Leukemia
      3. Prostate Cancer
      4. Lung Cancer
    3. Tissue Damage
      1. Trauma
      2. Surgery (e.g. Prostate Surgery)
      3. Heat Stroke
      4. Burn Injury
      5. Dissecting aneurysm
    4. Obstetrical Complication
      1. Abruptio Placentae
      2. Amniotic Fluid Embolism
      3. Retained fetal products on intrauterine fetal death
      4. Severe Preeclampsia
      5. HELLP Syndrome
      6. Acute Fatty Liver of Pregnancy
    5. Hemolytic disease
      1. Thrombotic Thrombocytopenic Purpura (TTP)
      2. Hemolytic Uremic Syndrome (HUS)
    6. Immunologic Disorders
      1. Immune complex disorders
      2. Allograft rejection
      3. Incompatible Blood Transfusion
      4. Anaphylaxis
    7. Metabolic
      1. Diabetic Ketoacidosis
    8. Miscellaneous
      1. Shock
      2. Snake Bite
      3. Cyanotic Congenital Heart Disease
      4. Fat embolism
      5. Severe liver disease
      6. Cavernous Hemangioma
  2. Pathophysiology
    1. Intravascular fibrin deposition occludes small vessels
      1. Microemboli or thrombi form in vasculature
    2. Consumptive coagulopathy
      1. Widespread coagulation activation depletes factors
      2. Factors depleted
        1. Platelets
        2. Antithrombin III
        3. Protein C
        4. Tissue factor pathway inhibitor
  3. Signs and symptoms
    1. Profuse bleeding from many sites
      1. Needle puncture site bleeding
      2. Mucosal bleeding
      3. Surgical incision or Laceration bleeding
      4. Multiple bruises or Petechiae
    2. Thrombosis
      1. End organ ischemia or infarction
      2. Multi-system failure
    3. Associated conditions
      1. Acute Tubular Necrosis
      2. Adult Respiratory Distress Syndrome
      3. Purpura fulminans
  4. Labs: Initial
    1. Platelet Count <100,000/mm3
    2. Fibrinogen <300 mg/dl
    3. Fibrin split product >40 mg/dl
    4. Prothrombin Time (aPT) >14 seconds or INR increased
    5. Partial Thromboplastin Time >40 seconds
    6. D-Dimer
      1. Early indicator of DIC in Preeclampsia
      2. Trofatter (1989) Obstet Gynecol 73:435-40
  5. Labs: Monitoring (every 2 hours in DIC)
    1. Platelet Count
    2. Fibrinogen
  6. Management
    1. Supportive care
      1. ABC Management
      2. Cardiopulmonary support
    2. Treat underlying disorder
      1. Example: Delivery in pregnancy related DIC
      2. Example: Antibiotics in Sepsis
    3. Transfuse Blood Products as needed
      1. Packed Red Blood Cells
      2. Platelet Transfusion for platelets <20,000 to 40,000
      3. Fresh Frozen Plasma (preferred over Cryoprecipitate)
        1. Coagulation Factors
        2. Fibrinogen
    4. Heparin has been used in DIC (use is debated)
      1. Heparin continuous infusion at 300 to 500 IU/hour
  7. References
    1. Levi (1999) N Engl J Med 341:586-92

Dacarbazine (C0010927)

Definition (CHV) a kind of cancer treatment drug
Definition (CHV) a kind of cancer treatment drug
Definition (CHV) a kind of cancer treatment drug
Definition (NCI) A drug that is used to treat Hodgkin lymphoma and malignant melanoma and is being studied in the treatment of other types of cancer. It attaches to DNA in cells and may kill cancer cells. It is a type of alkylating agent.
Definition (MSH) An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564)
Definition (NCI) A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. (NCI04)
Definition (CSP) cytotoxic alkylating agent used as an antineoplastic primarily for treatment of malignant melanoma and in combination chemotherapy for Hodgkin's disease and sarcomas; administered intravenously; abbreviated DTIC.
Definition (PDQ) A triazene derivative with antineoplastic activity. Dacarbazine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39768&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39768&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C411" NCI Thesaurus)
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D003606
SnomedCT 387441003, 77750008
English Carboxamide, Dimethyl Imidazole, Dacarbazine, Decarbazine, DIC, Dimethyl Imidazole Carboxamide, Dimethyl Triazeno Imidazole Carboxamide, DTIC, ICDT, Imidazole Carboxamide, Dimethyl, dacarbazine, 1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-, 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide, 1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-, 4-(Dimethyltriazeno)imidazole-5-carboxamide, 5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide, 5-(3-3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide, 5-(Dimethyltriazeno)imidazole-4-carboxamide, 5-(dimethyltriazeno)imidazole-4-carboxamide, Dacarbazine - DTIC, Dakarbazin, Imidazole Carboxamide Dimethyltriazeno, Dacarbazina, Dimethyl (triazeno) imidazolecarboxamide, Dimethyl Triazeno Imidazol Carboxamide, dimethyltriazenoimidazole carboxamide, dacarbazine (medication), DACARBAZINE, Dacarbazine [Chemical/Ingredient], Dacarbazine (DTIC), dtic, Dimethyl-triazeno-imidazole carboxamide, DIC - Dacarbazine, DTIC - Dacarbazine, Dacarbazine (product), Dacarbazine (substance), dimethyl-triazeno-imidazole carboxamide, Dimethyl-triazeno-imidazole-carboximide
Swedish Dakarbazin
Czech dakarbazin
Finnish Dakarbatsiini
Russian DAKARBAZIN, DTIC, ДАКАРБАЗИН
Italian DIC, Decarbazina, Dimetil-triazeno-imidazol-carbossamide, Dimetil imidazolo carbossamide, ICDT, DTIC, Dacarbazina
Spanish Dacarbazina, Dacarbacina, dacarbazina (producto), dacarbazina (sustancia), dacarbazina, dimetil-triazeno-imidazol carboxamida, DTIC
Polish Dakarbazyna, DTIC
French Dacarbazine
German DTIC, Dacarbazin
Portuguese DTIC, Dacarbazina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree